ClassID:

21497

A61K49/1809 - CPC Classification

Classification description:

Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes; Suspensions, emulsions, colloids, dispersions Micelles, e.g. phospholipidic or polymeric micelles

Recent Application in this class:
#1
20250243325
2025-07-31

PHOSPHORUS-31 MRI AGENTS

#2
20250129118
2025-04-24

MELANOCORTIN 1 RECEPTOR LIGANDS AND METHODS OF USE

#3
20250121100
2025-04-17

COMPOSITION AND METHOD FOR DIAGNOSTIC IMAGING

#4
20250082787
2025-03-13

ALGINIC ACID-BASED INJECTABLE HYDROGEL SYSTEM

#5
20240189230
2024-06-13

PALM FOR THE TREATMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY INCIDENTAL TO THE TREATMENT OF CANCER

#6
20230285292
2023-09-14

COMPOSITIONS AND METHODS OF USING A PLA2-RESPONSIVE DRUG DELIVERY SYSTEM

#7
20230167154
2023-06-01

Melanocortin 1 receptor ligands and methods of use

#8
20230087405
2023-03-23

AMPHIPHILIC POLYMERS AND THEIR USE FOR IMPROVED PRODUCTION OF NANOPARTICLES FOR THE TARGETED DELIVERY OF ANTIGENS

#9
20230066723
2023-03-02

MICROPARTICLE COMPOSITIONS

#10
20220143225
2022-05-12

ULTRAFINE IRON OXIDE NANOPARTICLE-BASED MAGNETIC RESONANCE IMAGING T1 CONTRAST AGENT

#11
20210379214
2021-12-09

Phospholipid-Free Small Unilamellar Vesicles (PFSUVS) for Drug Delivery

#12
20210369875
2021-12-02

ALGINIC ACID-BASED INJECTABLE HYDROGEL SYSTEM

#13
20210052749
2021-02-25

AMPHIPHILIC POLYMER NANO MICELLE CONTAINING POLY-3,4-DIHYDROXYPHENYLALANINE CHELATED FERRIC IONS

#14
20200170946
2020-06-04

Nanoparticle-lipid composite carriers and uses thereof

#15
20200046841
2020-02-13

Porphyrin modified telodendrimers

#16
20200002376
2020-01-02

Melanocortin 1 receptor ligands and methods of use

#17
20190192420
2019-06-27

USE OF A REVERSE-MICELLAR SYSTEM FOR DELIVERING CHELATORS OF RADIONUCLIDES AND METALS

#18
20180325821
2018-11-15

Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions

#19
20180317886
2018-11-08

Method of detecting microbubbles in a vessel

#20
20180169275
2018-06-21

POLYMERIC MICELLAR NANOPARTICLES

#21
20170224833
2017-08-10

SELF-ASSEMBLING MOLECULES THAT ACCUMULATE IN ACIDIC TUMOR MICROENVIRONMENTS

#22
20170218017
2017-08-03

Melanocortin 1 receptor ligands and methods of use

#23
20170143756
2017-05-25

Antitumor composition based on hyaluronic acid and inorganic nanoparticles, method of preparation thereof and use thereof

#24
20170035916
2017-02-09

Delivery system in micellar form having modular spectral response based on enzyme-responsive amphiphilic PEG-dendron hybrid polymers

#25
20170035909
2017-02-09

Use of a reverse-micellar system for delivering chelators of radionuclides and metals

#26
20170000910
2017-01-05

Polyphosphazene delivery system for inorganic nanocrystals

#27
20170000909
2017-01-05

ENZYME DIRECTED ASSEMBLY OF PARTICLE THERANOSTICS

#28
20160346408
2016-12-01

IRON STABILIZED MICELLES AS MAGNETIC CONTRAST AGENTS

#29
20160228580
2016-08-11

Mixed micelles

#30
20160220705
2016-08-04

Biodegradable organic radical-functionalized polycarbonates for medical applications

#31
20160199033
2016-07-14

Method for quantifying the characteristics of an object treated with a contrast agent

#32
20160058893
2016-03-03

MICROPARTICLE COMPOSITIONS

#33
20160038605
2016-02-11

Porphyrin modified telodendrimers

#34
20150071863
2015-03-12

Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof

#35
20150064116
2015-03-05

Multilayered magnetic micelle compositions and methods for their use

#36
20140363378
2014-12-11

SELF-ASSEMBLING MOLECULES THAT ACCUMULATE IN ACIDIC TUMOR MICROENVIRONMENTS

#37
20140294982
2014-10-02

Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions

#38
20140178310
2014-06-26

Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents

#39
20140112873
2014-04-24

Melanocortin 1 receptor ligands and methods of use

#40
20130309176
2013-11-21

Chelate nanoemulsion for MRI

#41
20130289398
2013-10-31

Medical imaging contrast devices, methods, and systems

#42
20130204181
2013-08-08

DUAL-MODAL IMAGING-GUIDED DRUG VEHICLE WITH ULTRASOUND-TRIGGERED RELEASE FUNCTION

#43
20120294809
2012-11-22

Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof

#44
20120225017
2012-09-06

Mixed micelles

#45
20120141382
2012-06-07

Aptamer modulators of complement protein C3 and biologically active proteolytic products thereof

#46
20120128589
2012-05-24

Perfluoro Compounds For Use In Imaging

#47
20110195030
2011-08-11

NANOPARTICLE COMPOSITIONS COMPRISING LIQUID OIL CORES

#48
20110135571
2011-06-09

HYBRID NANOPARTICLES AS ANTI-CANCER THERAPEUTIC AGENTS AND DUAL THERAPEUTIC/IMAGING CONTRAST AGENTS

#49
20100297019
2010-11-25

Particles for imaging

#50
20100158812
2010-06-24

Anti-cancer medicine both for diagnosing and treating cancer

#51
20090264397
2009-10-22

Highly fluorinated oils and surfactants and methods of making and using same

#52
20090196826
2009-08-06

COMPOSITIONS AND METHODS OF MAKING NON-SPHERICAL MICRO- AND NANO-PARTICLES

#53
20080311048
2008-12-18

Imaging Agent

#54
20070258908
2007-11-08

Detection and imaging of target tissue

#55
20070258886
2007-11-08

Methods for assessing cell labeling

#56
20070253899
2007-11-01

Dual function polymer micelles

#57
20070232909
2007-10-04

Ultrasonic Characterization of Internal Body Conditions Using Information Theoretic Signal Receivers

#58
20070140973
2007-06-21

CONTRAST AGENTS FOR MYOCARDIUM PERFUSION IMAGING

#59
20070140965
2007-06-21

Methods to ameliorate and image angioplasty-induced vascular injury

#60
20060287404
2006-12-21

Pharmaceutical raw material

#61
20060269479
2006-11-30

Amphiphilic polymers and methods of use thereof

#62
20060014938
2006-01-19

Stable aqueous colloidal lanthanide oxides